CDC, FDA announce changes for Pfizer’s COVID-19 vaccine

Jan 04, 2022 - 03:11 PM
cdc-update

The Centers for Disease Control and Prevention today announced a pair of changes to its recommendations regarding Pfizer’s COVID-19 vaccine. CDC is shortening its recommended interval of when a Pfizer booster dose is appropriate, to five months. The interval recommendations for Johnson & Johnson (two months) and Moderna (six months) remain unchanged. The CDC is also recommending an additional primary vaccine dose for children between the ages of 5 and 11 who are moderately or severely immunocompromised. This change only applies to Pfizer, as it is the only COVID-19 vaccine authorized and recommended for this age group.
 
The Food and Drug Administration, meanwhile, on Jan. 3 announced several amendments to Pfizer’s emergency use authorization that correspond with CDC’s recommendations. Additionally, FDA said it is expanding the use of a single booster dose to include individuals between the ages of 12 and 15.
 

Related News Articles

Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
CDC adopts ACIP recommendations for COVID-19, chickenpox vaccines
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…